Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue


Phase 4 Results N/A

Summary of Purpose

The high levels of fatigue in stroke patients without neurological impairment suggest it has a central origin rather than being the result of increased physical effort required after stroke(Winward et al., 2009). Fatigue is different from post-stroke depression and the more serious stroke patients are more prone to fatigue(Windward et al., 2009). Fatigue is one of the symptoms of qi deficiency,and Astragalus...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 March 2012.

1 Jan 2012 7 Mar 2012 1 Dec 2013 Unavailable 1 Mar 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • Chung Hsiang Liu, MD.